Market Closed

YDES
YD Bio Limited Ordinary Shares
$ 4.88
-6.15%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

YD Bio Limited Ordinary Shares News

Latest YD Bio Limited Ordinary Shares Stock News & YDES Headlines

YD Bio Announces FDA Grant of INTERACT Meeting Request for YDB-LMSCEV-001, an Investigational Extracellular Vesicle Candidate for Dry Eye Disease
3 days ago | globenewswire.com
YD Bio (NASDAQ:YDES) Stock Crosses Above 200-Day Moving Average – Here’s What Happened
19 days ago | defenseworld.net
YD Bio and EG BioMed Partner with JoiiUp to Launch AI-Driven Cancer Risk Assessment for Corporate Wellness Programs
a month ago | globenewswire.com
YD Bio Limited (NASDAQ:YDES) Sees Significant Increase in Short Interest
a month ago | defenseworld.net
YD Bio and EG BioMed Launch AI-Based 10-Cancer Risk Factor Assessment
a month ago | globenewswire.com
YD Bio (NASDAQ:YDES) Shares Down 4.4% – Here’s Why
a month ago | defenseworld.net
YD Bio Limited (NASDAQ:YDES) Sees Large Increase in Short Interest
2 months ago | defenseworld.net
YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026
3 months ago | globenewswire.com
YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
3 months ago | globenewswire.com
Head-To-Head Comparison: YD Bio (NASDAQ:YDES) versus Arbutus Biopharma (NASDAQ:ABUS)
3 months ago | defenseworld.net
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

YDES
YD Bio Limited Ordinary Shares
$ 4.88
-6.15%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago